GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

Hims & Hers (HIMS) has launched an online GLP-1 supply tracker where people can share information about where the popular ...

Patients who would benefit from a GLP-1 face significant challenges when it comes to access. Shortages have made it difficult ...

Pharmacies that make customized medications are asking the federal Food and Drug Administration to protect their right to ...

New data shows that government-funded health insurance plans in the United States provide the majority of coverage for ...

Hims & Hers is launching a tracker of GLP-1 shortages to push back against the FDA's recent moves to end compounding copycats ...

With brand-name GLP-1s for obesity treatment on and off the shortage list, prescribing can get complicated. Five providers ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

Lentils are full of fiber, which “slows down digestion,” once again reproducing the effect of the GLP-1 drugs, at a cost of ...

It's possible that Alzheimer's disease could be added to the lengthening list of ... injectable GLP-1 agonist liraglutide in people with early-stage Alzheimer's has shown that the drug was able ...

The bold move has been accompanied by a full-page ad in the Wall Street Journal explaining its reasoning, and claiming that the prices of GLP-1 drugs for weight loss are five times too high and ...

In this webinar, you’ll learn about GLP-1 agonists that can help with obesity treatment, common side effects of these drugs, misunderstandings about their use, and more. This webinar was ...